跳至主要内容
临床试验/CTRI/2023/09/058098
CTRI/2023/09/058098已完成3 期

A Prospective, Single Arm, Clinical Study To Evaluate TheEfficacy And Safety Of Glaze 5-In-1 Acne Control FormulaIn Patients With Acne Vulgaris - NI

Pontika Aerotech Limited0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Healthy male or female subjects in the age group of 18-45 years
  • 2.Healthy skin in the test areas;
  • 3.Subjects willing and capable to follow the study rules and a fixed schedule;
  • 4.Ability of giving consent for participation in the study;
  • 5.Subjects with good health in general and good mental condition;
  • 6.Subjects who present at least 10 inflammatory lesions;
  • 7.Oily skin on the face

排除标准

  • 1.Pregnancy or breastfeeding;
  • 2.Subjects who present severe acne;
  • 3.Subjects who present more than two nodular lesions;
  • 4.Subjects who changed their oral contraception method up to three months before the study beginning;
  • 5.Subjects who did acne hormonal treatment less than 6 months before the study;
  • 6.Subjects who did oral isotretinoïne treatment less than 1 month before the study;
  • 7.Subjects who did topical acne treatment less than 90 months before the study;
  • 8.Subjects who did aesthetic treatment less than 6 months before the study (like laser and peeling);
  • 9.Subjects who did treatment with antibiotics within the last 4 months;
  • 10.Simultaneous participation in different studies from external research institutes on the same test sites
  • 11.Hypersensitivity to any of the ingredients of the test product.
  • 12.Pregnant or lactating women
  • 13.Patients on steroid therapy or any other immunomodulatory agents

研究者

发起方
Pontika Aerotech Limited

相似试验